Owner Genencor International, Inc.

Inventors Van Kimmenade, Anita; Day, Anthony; Schmidt, Brian; Murray, Christopher J.; Estell, David A.; Ganshaw, Grant C.; Power, Scott D.; De Nobel, Hans; Miller, Jeffrey V.; Collier, Katherine D.; Kolkman, Marc; Lad, Raj; Vogtentanz, Gudrun

Agent Houlihan2

Pub. Number AU-A-2012203584

Parent 2006246425

Filing date 20 June 2012

Wipo publication date 12 July 2012

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 8/64 Cosmetics or similar toilet preparations

A61K 38/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/81 Peptides having more than 20 amino acids - Protease inhibitors

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 9/99 Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C12N 15/74 Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora